Search

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.

The integration of artificial intelligence (AI) into healthcare systems has transformed population health analytics, enabling scalable infrastructures that process vast datasets to inform clinical decisions, resource allocation, and policy-making. This narrative review synthesizes recent literature on AI system architectures and governance models, focusing on how these elements underpin analytics-driven healthcare ecosystems. We examine the evolution of AI-enabled infrastructures, emphasizing federated learning, explainable models, and ethical frameworks to address data privacy, interoperability, and equity in population-level analytics. Key architectures include vertically integrated systems that streamline data ingestion, model deployment, and real-time inference, as seen in federated approaches that mitigate data silos while preserving patient confidentiality. Governance models are critical for ensuring trustworthy AI deployment, incorporating regulatory oversight, ethical principles adapted from military contexts to healthcare, and consensus-based guidelines for prediction models. We highlight the role of blockchain and data trusts in enhancing transparency and consent mechanisms, particularly in global health responses to pandemics and chronic disease management. The review structures the discourse around systems-level framing, integrating data flows, algorithmic decision support, and closed-loop feedback mechanisms that adapt to clinical outcomes. For instance, electronic health record (EHR)-based prediction models facilitate acute illness forecasting and outcome prediction in conditions like rheumatoid arthritis and oncology. We propose an original synthesis logic that conceptualizes AI infrastructures as adaptive networks, where governance acts as a regulatory layer overlaying architectural components to balance innovation with risk mitigation. Challenges such as bias in commercial datasets and the need for international cooperation are noted, but the emphasis remains on infrastructural resilience. Ultimately, this synthesis underscores the imperative for hybrid human-AI systems that prioritize population health equity, with governance models evolving to support sustainable analytics infrastructures. By positioning AI as a foundational tool for healthcare transformation, the review advocates for interdisciplinary collaboration to refine these systems, ensuring they deliver actionable insights while upholding ethical standards in diverse healthcare settings.

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling predictive modeling, diagnostic support, and personalized interventions. However, the post-deployment phase of these AI systems presents unique challenges, particularly in maintaining performance amid evolving clinical environments. This narrative review synthesizes recent literature on post-deployment monitoring strategies for clinical AI, focusing on drift detection, feedback governance, and update policies within healthcare systems and analytics frameworks. We examine how data shifts—arising from changes in patient demographics, clinical protocols, or external factors—can degrade AI model efficacy, leading to suboptimal outcomes in high-stakes settings like disease prediction and resource allocation. Drift detection emerges as a cornerstone, encompassing statistical methods to identify concept drift, covariate shift, and label drift in real-time healthcare data streams. Techniques such as nonparametric monitoring and ensemble-based approaches allow for proactive identification of performance decay, ensuring AI systems remain aligned with dynamic clinical realities. Feedback governance integrates human-in-the-loop mechanisms, where clinician inputs refine AI outputs, fostering trust and regulatory compliance in governance structures. Update policies, including retraining schedules and federated learning paradigms, to address the need for iterative model evolution without disrupting clinical workflows. We highlight systems-level perspectives, such as closed-loop architectures that link monitoring to automated updates, emphasizing interoperability across electronic health records (EHRs) and AI pipelines. Comparative analysis reveals gaps in current practices, including limited scalability in resource-constrained settings and ethical considerations in data privacy during monitoring. Through an original synthesis, we propose an integrative framework for AI lifecycle management in healthcare, underscoring the interplay between drift metrics, governance protocols, and policy-driven updates to enhance patient safety and system resilience. This review underscores the imperative for standardized monitoring protocols, informed by multidisciplinary insights, to bridge the translational gap from AI development to sustained clinical utility. By addressing these elements, healthcare AI can achieve robust, adaptive performance, ultimately improving analytics-driven decision-making and outcomes in diverse clinical contexts. Future directions include harmonizing international guidelines for AI monitoring, integrating explainable AI for better feedback loops, and leveraging emerging technologies like edge computing for real-time drift management. This synthesis provides a foundation for researchers and practitioners to advance post-deployment strategies, ensuring AI’s enduring impact on healthcare systems.

Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide, with prevalence expected to triple by 2050. Early detection is crucial for clinical trial enrollment and care planning, and multimodal data (MRI, PET, CSF biomarkers, and cognitive assessments) provides complementary information on neurodegeneration, metabolism, and protein aggregation. This systematic review synthesizes AI/ML approaches for early AD detection using multimodal data, focusing on fusion strategies and performance across disease stages. Following PRISMA guidelines, searches of PubMed, IEEE Xplore, Scopus, Web of Science, and arXiv (2017–2023) identified studies using ML/DL with at least two modalities and reporting diagnostic performance. From 1,247 records, 35 studies were included. MRI was the most used modality (>90%), followed by cognitive tests (70–80%), PET (40–50%), and CSF (20–30%). Early fusion was most common, with increasing use of intermediate fusion. Multimodal models achieved AUROC of 0.90–0.98 for AD vs controls, but lower performance (0.70–0.85) for predicting MCI conversion to AD. Overall, multimodal AI improves early AD detection, with strong performance for diagnosis but persistent challenges in forecasting MCI progression due to heterogeneity and limited longitudinal data.